PSMD2 and breast carcinoma: In breast cancer, reported that upregulation of PSMD2 is associated with shorter overall survival and distant-metastasis-free survival, further suggesting that PSMD2 could act as a factor for an unfavorable prognosis in breast cancer Li et al. (2018).